abstract |
Antibodies selectively binding to glycosylated PD-1 are provided relative to non-glycosylated PD-1. In some embodiments, a PD-I polypeptide comprising a glycosylated amino acid position is also provided. Methods are also provided for making and using said antibodies and polypeptides (e.g., for the treatment of cancer). |